Hyloris Rolls Out Maxigesic IV In Europe

Germany And Austria Are Initial European Launch Markets

 
• By Dave Wallace

Hyloris has launched its Maxigesic IV value-added medicine in Germany and Austria, taking to five its total number of commercialized markets for the non-opioid intravenous analgesic.

Germany Austria Flags
Hyloris has launched its Maxigesic IV in Germany and Austria • Source: Alamy

More from Value Added Medicines

More from Products